Skip to main content

Advertisement

Log in

Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis

  • Review
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

Coinfections of hepatitis C virus (HCV) and/or hepatitis B virus (HBV) with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) are associated with high morbidity and mortality and poor prognosis. The main objective of this study was to evaluate the prevalence of HCV and/or HBV coinfections among people who inject drugs (PWID) and female sex workers (FSWs) who live with HIV/AIDS worldwide. Data sources were searched from January 2008 to October 2018 in different databases, including PubMed, Scopus, Web of Science, Embase, and Ovid. Data were analyzed in Stata 14 software using the Metaprop command. The results showed that the prevalence of HCV among PWID and FSWs with HIV/AIDS was 72% (95% CI: 59%-83%) and 40% (95% CI: 0%-94%), respectively. The prevalence of HBV among PWID and FSWs with HIV/AIDS was 8% (95% CI: 5%-13%) and 2% (95% CI: 0%-7%), respectively, and the prevalence of HCV/HBV in PWID with HIV/AIDS was 11% (95% CI: 7%-15%). The highest prevalence of HCV was observed in PWID in the Eastern Mediterranean and Europe regions, and the lowest was observed in the Africa region. The South-East Asia region had the highest prevalence of HBV among PWID, and the Africa region had the lowest prevalence. The high prevalence of HCV coinfection among PWID and FSWs with HIV/AIDS was an alarming health problem and requires appropriate interventions. Therefore, considering that these populations are key populations for HCV elimination, it is recommended to screen them regularly for HCV. In addition, harm reduction and HBV vaccination should be carefully considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

HIV/AIDS:

Human immunodeficiency virus/acquired immune deficiency syndrome

PWID:

People who inject drugs

FSWs:

Female sex workers

WHO:

World Health Organization

PLWHA:

People who live with HIV/AIDS

References

  1. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1736–1788

    Google Scholar 

  2. UNAIDS (2019) https://www.unaids.org/en/resources/fact-sheet.

  3. WHO, HIV/AIDS (2019) https://www.who.int/en/news-room/fact-sheets/detail/hiv-aids.

  4. WHO h (2018) https://www.who.int/hepatitis/news-events/hbv-cure-overview/en.

  5. WHO, C H (2019) https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-c.

  6. WHO, B H (2019) https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b.

  7. UNAIDS WAeuDG, Switzerland: United Nations Programme on HIV/AIDS and World Health Organization (UNAIDS & WHO)

  8. Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K (2017) Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health 5(12):e1192–e1207. https://doi.org/10.1016/S2214-109X(17)30375-3

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L (2011) Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 378(9791):571–583

    PubMed  PubMed Central  Google Scholar 

  10. Mohsen A, Easterbrook P, Taylor C, Norris S (2002) Hepatitis C and HIV-1 coinfection. Gut 51(4):601–608

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Konopnicki D, Mocroft A, De Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD (2005) Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. Aids 19(6):593–601

    PubMed  Google Scholar 

  12. Lacombe K, Rockstroh J (2012) HIV and viral hepatitis coinfections: advances and challenges. Gut 61(Suppl 1):i47–i58

    CAS  PubMed  Google Scholar 

  13. Klein MB, Lalonde RG (1999) Suissa S (2003) The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 33(3):365–372

    Google Scholar 

  14. Thio CL (2003) Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. In: Seminars in liver disease. vol 02. Copyright© 2002 by Thieme Medical Publishers, Inc., New York, pp 125–136

  15. Hosseini Rad M, Jamshidi Makiani M, Kalantari S, Sohrabi S, Ahmadniya H, Zanganeh M (2017) The study of seroprevalence of hepatitis B and hepatitis C and behavioral factors in HIV patients referred to the consultation clinics of Tehran Behavioral Diseases Health Center. Med Sci J Islamic Azad Univ Tehran Med Branch 27(1):53–61

    Google Scholar 

  16. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Muñoz A, Thomas DL (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360(9349):1921–1926

    PubMed  Google Scholar 

  17. Schüttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S (2002) Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 37(6):855–862

    PubMed  Google Scholar 

  18. Drosten C, Nippraschk T, Manegold C, Meisel H, Brixner V, Roth WK, Apedjinou A, Günther S (2004) Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus. J Clin Virol 29(1):59–68

    CAS  PubMed  Google Scholar 

  19. Sulkowski MS (2008) Viral hepatitis and HIV coinfection. J Hepatol 48(2):353–367

    CAS  PubMed  Google Scholar 

  20. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012

    CAS  PubMed  Google Scholar 

  21. Lambdin BH, Lorvick J, Mbwambo JK, Rwegasha J, Hassan S, Lum P, Kral AH (2017) Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. Int J Drug Policy 45:64–69

    PubMed  PubMed Central  Google Scholar 

  22. Khatib A, Matiko E, Khalid F, Welty S, Ali A, Othman A, Haji S, Dahoma M, Rutherford G (2017) HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar. BMC Public Health 17(1):917

    PubMed  PubMed Central  Google Scholar 

  23. Jordan AE, Des Jarlais DC, Arasteh K, McKnight C, Nash D, Perlman DC (2015) Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006–2013. Drug Alcohol Depend 152:194–200

    PubMed  PubMed Central  Google Scholar 

  24. Hsieh M-H, Tsai J-J, Hsieh M-Y, Huang C-F, Yeh M-L, Yang J-F, Chang K, Lin W-R, Lin C-Y, Chen T-C, Huang J-F, Dai C-Y, Yu M-L, Chuang W-L (2014) Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection. PLoS ONE 9(4):e94791. https://doi.org/10.1371/journal.pone.0094791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Kuniholm MH, Aladashvili M, Rio CD, Stvilia K, Gabelia N, Chitale RA, Tsertsvadze T, Nelson KE (2008) Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia. Subst Use Misuse 43(10):1424–1437

    PubMed  PubMed Central  Google Scholar 

  26. Alaei A, Alaei K, Waye K, Tracy M, Nalbandyan M, Mutlu E, Cetin M (2017) Hepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkey. J Viral Hepatitis 24(6):496–505

    CAS  Google Scholar 

  27. Pilon R, Leonard L, Kim J, Vallee D, De Rubeis E, Jolly AM, Wylie J, Pelude L, Sandstrom P (2011) Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs. PLoS ONE 6(7):e22245

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Solomon SS, Srikrishnan AK, Mehta SH, Vasudevan CK, Murugavel KG, Thamburaj E, Anand S, Kumar MS, Latkin C (1999) Solomon S (2008) High prevalence of HIV, HIV/hepatitis C virus co-infection and risk behaviors among IDUs in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr 49(3):327

    Google Scholar 

  29. Jõgeda EL, Avi R, Pauskar M, Kallas E, Karki T, Des Jarlais D, Uusküla A, Toompere K, Lutsar I, Huik K (2018) Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs. J Med Virol 90(11):1779–1783

    PubMed  PubMed Central  Google Scholar 

  30. Ruiseñor-Escudero H, Wirtz AL, Berry M, Mfochive-Njindan I, Paikan F, Yousufi HA, Yadav RS, Burnham G, Vu A (2014) Risky behavior and correlates of HIV and hepatitis C virus infection among people who inject drugs in three cities in Afghanistan. Drug Alcohol Depend 143:127–133

    PubMed  Google Scholar 

  31. Davoodian P, Dadvand H, Mahoori K, Amoozandeh A (2002) Salavati A (2009) Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran. Braz J Infect Dis 13(5):356–358

    Google Scholar 

  32. Demissie M, Johnston LG, Muleta M, Desyebelew D, Belete W, G/Egxiabehre A, Gezahegn N, Kassa D, Aseffa Y (2018) Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia. Afr J AIDS Res 17(3):259–264

    PubMed  Google Scholar 

  33. Mansha S, Imran M, Shah A, Jamal M, Ahmed F, Atif M, Saleem M, Safi SZ, Fatima Z, Bilal Waqar A (2017) Hepatitis B and C virus infections among human immunodeficiency virus-infected people who inject drugs in Lahore, Pakistan. Viral Immunol 30(5):366–370. https://doi.org/10.1089/vim.2016.0144

    Article  CAS  PubMed  Google Scholar 

  34. Mahanta J, Borkakoty B, Das HK, Chelleng PK (2009) The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care 21(11):1420–1424

    PubMed  Google Scholar 

  35. Garfein RS, Rondinelli A, Barnes RF, Cuevas J, Metzner M, Velasquez M, Rodriguez D, Reilly M, Xing J, Teshale EH (2013) HCV infection prevalence lower than expected among 18–40-year-old injection drug users in San Diego, CA. J Urban Health 90(3):516–528

    PubMed  Google Scholar 

  36. McFall AM, Solomon SS, Lucas GM, Celentano DD, Srikrishnan AK, Kumar MS, Mehta SH (2017) Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study. Addiction 112(8):1480–1487

    PubMed  PubMed Central  Google Scholar 

  37. da Silva CM, de Peder LD, Guelere AM, Horvath JD, Silva ES, Teixeira JJV, Bertolini DA (2018) Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil. PLoS ONE 13(9):e0203272

    PubMed  PubMed Central  Google Scholar 

  38. Ionita G, Malviya A, Rajbhandari R, Schluter WW, Sharma G, Kakchapati S, Rijal S, Dixit S (2017) Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study. Int J Infect Dis 60:64–69

    CAS  PubMed  Google Scholar 

  39. Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J (2015) Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study. Adv Virol 160(4):929–936

    CAS  Google Scholar 

  40. Yan Y, Gao Y, Sun X, Wang W, Huang X, Zhang T, Li M, Zang C, Li Z, Wu H (2011) Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect 139(3):354–360

    CAS  PubMed  Google Scholar 

  41. Schuelter-Trevisol F, Custodio G, Silva ACBd, Oliveira MBd, Wolfart A, Trevisol DJ (2013) HIV, hepatitis B and C, and syphilis prevalence and coinfection among sex workers in Southern Brazil. Rev Soc Bras Med Trop 46(4):493–497

    PubMed  Google Scholar 

  42. Johnston LG, Corceal S (2013) Unexpectedly high injection drug use, HIV and hepatitis C prevalence among female sex workers in the Republic of Mauritius. AIDS Behav 17(2):574–584

    PubMed  Google Scholar 

  43. Haussig JM, Nielsen S, Gassowski M, Bremer V, Marcus U, Wenz B, Bannert N, Bock C-T, Zimmermann R, group Ds (2018) A large proportion of people who inject drugs are susceptible to hepatitis B: results from a bio-behavioural study in eight German cities. Int J Infect Dis 66:5–13

    CAS  PubMed  Google Scholar 

  44. Shethwala ND, Mulla SA, Kosambiya J, Desai VK (2009) Sexually transmitted infections and reproductive tract infections in female sex workers. Indian J Pathol Microbiol 52(2):198

    PubMed  Google Scholar 

  45. Kotaki T, Khairunisa SQ, Sukartiningrum SD, Arfijanto MV, Utsumi T, Normalina I, Handajani R, Widiyanti P, Rusli M, Rahayu RP (2013) High prevalence of HIV-1 CRF01_AE viruses among female commercial sex workers residing in Surabaya, Indonesia. PLoS ONE 8(12):e82645

    PubMed  PubMed Central  Google Scholar 

  46. Soriano V, Barreiro P, Nuñez M (2006) Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother 57(5):815–818

    CAS  PubMed  Google Scholar 

  47. Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, Yanny I, Razavi H, Vickerman P (2016) Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis 16(7):797–808

    PubMed  Google Scholar 

  48. Johnston L, Saumtally A, Corceal S, Mahadoo I, Oodally F (2011) High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey. Int J Drug Policy 22(4):252–258

    PubMed  Google Scholar 

  49. Webale MK, Budambula V, Lihana R, Musumba FO, Nyamache AK, Budambula NL, Ahmed AA, Ouma C, Were T (2015) Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya. BMC Infect Dis 15(1):299

    PubMed  Google Scholar 

  50. Origer A, Schmit J-C (2012) Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence. J Epidemiol Community Health 66(1):64–68

    PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Deputy of Research of Kurdistan University of Medical Sciences. This article is a part of master’s degree dissertation in epidemiology in 2018 entitled “Prevalence of HIV, Hepatitis C and B co-infection in People Who Inject Drug (PWID) and Female Sex Workers (FSWs) Worldwide; A Systematic Review and Meta-Analysis” which was recorded under code: IR.MUK.REC.1397/275.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ghobad Moradi.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Additional information

Handling Editor: YiMing Shao.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashti, R., Alavian, S.M., Moradi, Y. et al. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis. Arch Virol 165, 1947–1958 (2020). https://doi.org/10.1007/s00705-020-04716-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-020-04716-1

Navigation